Suggestions
Yosef Safi Harb
Founder & CEO Happitech | MTI 23' | Software as a Medical Device | Remote Cardiac Monitoring
Yosef Safi Harb is the founder and CEO of Happitech, a medical technology company based in Amsterdam that develops innovative heart monitoring solutions using smartphone cameras.12 Here are some key details about Yosef Safi Harb:
Background and Education
Yosef has a strong technical background:
- He is a Cum Laude Aerospace engineer with double degrees.3
- He studied at Delft University of Technology.5
- He has 7 years of mechatronic experience and holds 2 patents.34
Career and Happitech
Yosef founded Happitech in 2015 after being inspired by his father's struggle to get diagnosed with a heart condition.2 Some highlights of his work with Happitech include:
- Developing medical-grade heart monitoring technology using only a smartphone camera.1
- Achieving CE certification for their technology as a Class 2a medical device.2
- Expanding Happitech's presence to monitor over 30,000 atrial fibrillation patients monthly.2
- Working towards FDA clearance to enter the US market.2
Expertise and Leadership
As CEO, Yosef leads Happitech with:
- A vision to provide accessible cardiac monitoring globally.4
- Experience in navigating the complex medical device industry.2
- A focus on expanding Happitech's capabilities beyond atrial fibrillation detection.3
Personal
- Yosef is described as having a positive attitude, fitting for a company named Happitech.1
- He has a Twitter account @ysharb where he describes himself as interested in MedTech and Aerospace Engineering.6
- His LinkedIn username is indeed ysharb.5
Yosef Safi Harb has successfully transitioned from aerospace engineering to healthcare entrepreneurship, leading Happitech in its mission to revolutionize heart health monitoring using everyday technology.
Highlights
Huma has been working on something very exciting! Congrats on the raise Dan Vahdat and Dr Mert Aral.
Huma has completed a Series D funding round, raising over $80 million, and launched the Huma Cloud Platform integrated with GenAI. This new platform offers no-code configuration for regulated disease management tools, aiming to accelerate the development and launch of digital health projects.
Read all about it here and signup for the waiting list: https://lnkd.in/ej7Jvfb9
🌍📈 Atrial Fibrillation (AFib) is a growing global health concern, affecting millions and leading to severe complications such as stroke and heart failure. Here are some key insights from J&J MedTech:
Global Impact: Over 43 million people worldwide suffer from AFib, with a significant increase in cases from 1990 to 2019, particularly in high-income countries such as the USA and Europe.
Regional Prevalence: The highest prevalence rates are found in high-income North America and Europe, while the lowest rates are in Asia Pacific regions. The prevalence has been increasing notably in East Asia and Eastern Europe.
Health Burden: AFib increases the risk of stroke by 5 times and accounts for 20% of all strokes. The number of deaths related to AFib has also seen a significant rise, emphasizing the need for early diagnosis and effective management strategies.
Link in comments.
